Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors – a biomarker analysis of the <scp>ALICE</scp> and <scp>ICON</scp> trials
Nikolai Kragøe Andresen(Oslo University Hospital), Bjørn Naume(Norwegian Cancer Society)
Cited by 12
Related Papers
Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis
|JNCI Journal of the National Cancer Institute|2018|282
Genome-wide DNA methylation profiles in progression to in situand invasive carcinoma of the breast with impact on gene transcription and prognosis
|Genome biology|2014|179
NR2F1 stratifies dormant disseminated tumor cells in breast cancer patients
|Breast Cancer Research|2018|114